Retrovirus-like particles were secreted in a steroid-dependent manner by the human mammary carcinoma cell line T47D. The particles exhibited typical retroviral properties such as their electron microscopic appearance (95 nm in diameter) and occasional budding, sedimentation at 1.14 g/ml, reverse transcriptase activity and genomic RNA. The T47D particles were related to mouse mammary tumour virus (MMTV) as shown by their ultrastructural appearance (B type-like eccentric dense cores and budding), Mg2+ dependence of the reverse transcriptase activity; immunological reactivity with MMTV-directed antibodies (revealing proteins of 63K, 52K, 26K and 18K), and hybridization of particle RNA with MMTV DNA under stringent conditions. Purified particles were able to incorporate deoxynucleoside triphosphates in the absence of an exogenous primer and template, thus indicating the existence of a complete and biochemically functional reverse transcription apparatus (reverse transcriptase, RNA and primer) and the ability to direct endogenous cDNA synthesis. Labelled particle cDNA hybridized strongly to human genomic DNA but not to mouse and cat DNA, thus indicating the human origin of the T47D particles. Furthermore all human DNAs, hybridized with the labelled particle cDNA, showed a uniform hybridization pattern of restriction fragments, indicating the endogenous origin and distribution of the proviral particle DNA in the human genome.
Al-SumidaieA. M.,
HartC. A.,
LeinsterS. J.,
GreenC. D.,
McCarthyK.1988; Particles with properties of retroviruses in monocytes from patients with breast cancer. Lancet ii:5–9
AxelR.,
GulatiS. C.,
SpiegelmanS.1972b; Particles containing RNA-instructed DNA polymerase and virus-related RNA in human breast cancers. Proceedings of the National Academy of Sciences, U.S.A. 69:3133–3137
CallahanR.1988; Two families of human endogenous retroviral genomes. In Eukaryotic Transposable Elements as Mutagenic Agents: Banbury Report 30 pp 91–100 Edited by
LambertM. E.,
McDonaldI. F.,
WeinsteinI. B.
New York: Cold Spring Harbor Laboratory;
CallahanR.,
DrohanW.,
TronickS.,
SchlomJ.1982; Detection and cloning of human DNA sequences related to the mouse mammary tumor virus genome. Proceedings of the National Academy of Sciences, U.S.A. 79:5503–5507
ChoiY.,
KapplerJ. W.,
MarrackP.1991; A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumour virus. Nature, London 350:203–207
DeenK. C.,
SweetR. W.1986; Murine mammary tumor virus pol-related sequence in human DNA: characterization and sequence comparison with the complete murine mammary tumor virus pol gene. Journal of Virology 57:422–432
DysonP. J.,
KnightA. M.,
FairchildS.,
SimpsonE.,
TomonariK.1991; Genes encoding ligands for deletion of Vβ 11 T cells cosegregate with mammary tumour virus genomes. Nature, London 349:531–532
FrankelW. N.,
RudyC.,
CoffinJ. M.,
HuberB. T.1991; Linkage of Mis genes to endogenous mammary tumour viruses of inbred mice. Nature, London 349:526–528
FranklinG. C.,
ChretienS.,
HansonI. M.,
RochefortH.,
BayF. E. B.,
WestlyR.1988; Expression of human sequences related to those of mouse mammary tumor virus. Journal of Virology 62:1203–1210
GössnerW.,
HehlmannR.,
SchreiberM. S.,
LoheK. J.,
PrechtelF.1985; Immunohistochemical studies with retrovirusspecific antibodies in benign and malignant breast lesions. Verhandlungen der Deutschen Gesellschaft für Pathologie 69:249–253
GünzburgW. H.,
SalmonsB.1986; Mouse mammary tumor virus mediated transfer and expression of neomycin resistance to infected cultured cells. Virology 155:236–248
HehlmannR.,
BaumgartenA.,
SchreiberM. A.,
SchettersH.,
LuzA.,
Mesa-TejadaR.,
LoheK. J.,
PrechtelK.1981; Kreuzreaktion menschlicher Mammakarzinome mit dem Hullglyco-protein gp52 des Mausmamma-tumorvirus (MMTV). Verhandlungen der Deutschen Gesellschaft für Pathologie 65:275–279
HehlmannR.,
SchreiberM. S.,
KreebG.,
LuzA.,
Mesa-TejadaR.,
LoheK. J.,
PrechtelK.1983; Kreuzreaktionen menschlicher Mammakarzinome mit Mammatumorvirusantigenen und mögliche diagnostische Bedeutung. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 89:1025–1029
HüginA. W.,
VacchioM. S.,
MorseH. C.III1991; A virus-encoded “superantigen” in a retrovirus-induced immunodeficiency syndrome of mice. Science 252:424–427
ImberatiL.,
SottiniA.,
BettinardiA.,
PuotiM.,
PrimiD.1991; Selective depletion in HIV infection of T cells that bear specific T cell receptor Vβ sequences. Science 254:860–862
KahlL. P.,
CarrollA. R.,
RhodesP.,
WoodJ.,
ReodN. G.1991; An evaluation of the putative human mammary tumour retrovirus associated with peripheral blood monocytes. British Journal of Cancer 63:534–540
KeydarI.,
ChenL.,
KarbyS.,
WeissF. R.,
DelareaJ.,
RaduM.,
ChaitchickS.,
BrennerH. J.1979; Establishment and characterization of a cell line of human breast carcinoma origin. European Journal of Cancer 15:659–670
KeydarI.,
SelzerG.,
ChaitchikS.,
HareuveniM.,
KarbyS.,
HiziA.1982; A viral antigen as a marker for the prognosis of human breast cancer. European Journal of Cancer and Clinical Oncology 18:1321–1328
KeydarI.,
OhnoT.,
NayakR.,
SweetR.,
SimoniF.,
WeissF.,
KarbyS.,
Mesa-TejadaR.,
SpiegelmanS.1984; Properties of retrovirus-like particles produced by a human breast carcinoma cell line: immunological relationship with mouse mammary tumor virus proteins. Proceedings of the National Academy of Sciences, U.S.A. 81:4188–4192
KeydarI.,
TsarfatyJ.,
SmorodinskyN.,
SaharE.,
ShoenfeldY.,
ChaitchikS.1986; Human monoclonal antibodies directed against HuMTV antigens from human breast cancer cells. In New Experimental Modalities in the Control of Neoplasia pp 123–135 Edited by
ChandraP.
Nato Advanced Study Institute 1985 New York: Plenum Press;
Kyse-AndersonJ.1984; Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. Journal of Biochemical and Biophysical Methods 10:203–209
McGrathC. M.,
GrantP. H.,
SonleH. D.,
GlancyT.,
RichM. A.1972; Replication of oncornavirus-like particle in human breast carcinoma cell line, MCF-7. Nature, London 252:247–250
MayF. E.,
WestleyB. R.1989; Characterization of sequences related to the mouse mammary tumor virus that are specific to MCF-7 breast cancer cells. Cancer Research 49:3879–3883
Mesa-TejadaR.,
KeydarI.,
RamanarayananM.,
OhnoT.,
FenoglioC.,
SpiegelmanS.1978; Detection in human breast carcinomas of an antigen immunologically related to a group specific antigen of mouse mammary tumor virus. Proceedings of the National Academy of Sciences, U.S.A. 75:1529–1533
Mesa-TejadaR.,
OsterM. W.,
FenoglioC. M.,
MagidsonJ.,
SpiegelmanS.1982; Diagnosis of primary breast carcinoma through immuno-histochemical detection of mouse mammary tumor virus-related antigen in metastatic lesions. A report of two cases. Cancer 49:261–268
MichalidesR.,
SpiegelmanS.,
SchlomJ.1975; Biochemical characterisation of putative subviral particulates from malignant breast tumors. Cancer Research 35:1003–1008
MichalidesR.,
van OoyenA.,
NusseR.1983; Mouse mammary tumor virus expression and mammary tumor development. Current Topics in Microbiology and Immunology 106:57–78
MooreD. H.,
CharneyJ.,
KramarskyB.,
LasfarguesE. Y.,
SarkarN. H.,
BrennanM. J.,
BurrowsJ. H.,
SirsatS. M.,
PaymasterJ. C.,
VaidyaA. B.1971; Search for a human breast cancer virus. Nature, London 229:611–614
O’HehirR. E.,
LambJ. R.1990; Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureus enterotoxins. Proceedings of the National Academy of Sciences, U.S.A. 87:8884–8888
OhnoT.,
SweetR. W.,
HuR.,
DejykD.,
SpiegelmanS.1977; Purification and characterisation of the DNA polymerase of human breast cancer particles. Proceedings of the National Academy of Sciences, U.S.A. 14:764–768
OnoK.1989; Mechanisms of antiretroviral compounds in inhibition of viral and cellular DNA polymerase. In Perspectives in Antiinfective Therapy pp 51–59 Edited by
JacksonG. G.,
SchlumbergerH. D.,
ZeilerH. J.
Friedr. Vieweg & Sohn;
OnoM.,
YasunagaT.,
MiyataT.,
UshikuboH.1986; Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. Journal of Virology 60:589–598
OnoM.,
KavakamiM.,
UshikuboH.1987; Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. Journal of Virology 61:2059–2062
PaertakulU.,
de StasioP. R.,
TaylorM. W.1988; A fast and sensitive method for detecting specific viral RNA in mammalian cells. Journal of Virology 62:1132–1135
PoieszB. J.,
RuscettiF. W.,
GazdarA. F.,
BunnP. A.,
MinnaJ. D.,
GalloR. C.1980; Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences, U.S.A. 77:7415–7419
PontaH.,
KennedyN.,
HerrlichP.,
HynesN. E.,
GronerB.1983; A deletion mutant of mouse mammary tumour virus, lacking 516 nucleotides of the 5′ long terminal repeat sequence, can be expressed in a hormone-responsive fashion. Journal of General Virology 64:567–577
RedinbaughM. G.,
TurleyR. B.1986; Adaptation of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions. Analytical Biochemistry 153:267–271
SegevN.,
HiziA.,
KirenbergF.,
KeydarI.1985; Characterization of a protein, released by the T47D cell line, immunologically related to the major envelope protein of mouse mammary tumor virus. Proceedings of the National Academy of Sciences, U.S.A. 82:1531–1535
SmithP. K.,
KrohnR. J.,
HermansonG. T.,
MalliaA. K.,
GartnerF. H.,
ProvenzanoM. D.,
FujimotoE. K.,
GoekeN. M.,
OlsonB. J.,
KlenkD. C.1985; Measurement of protein using bicinchoninic acid. Analytical Biochemistry 150:76–85
VaidyaA. B.,
BlackM. M.,
DionA. S.,
MooreD. H.1974; Homology between human breast tumour RNA and mouse mammary tumour virus genome. Nature, London 249:565–567
WeissR.1984; The search for human RNA tumor viruses. In RNA Tumor Viruses pp 1205–1281 Edited by
WeissR.,
TeichN.,
VarmusH.,
CoffinJ.
New York: Cold Spring Harbor Laboratory;